Regen BioPharma Reports Success of its NR2F6 Small Molecule Screening Program for Treating Autoimmune Diseases Read more
Evotec and Centogene sign global strategic partnership on drug discovery projects in rare genetic diseases Read more
CNDA grants rapid approval of Roche’s Alecensa (alectinib) as a treatment for ALK-positive lung cancer Read more
Tagrisso approved in Japan for 1st-line treatment of EGFR-mutated non-small cell lung cancer Read more